Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

1131885

registered interest
date	12/06/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Heathrow Airport: Railways
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to review the performance of Transport for London in relation to the frequency and reliability of the shuttle service between Heathrow Central and Terminal 4 to ensure a regular service every 10 minutes in each direction every day.
tabling member printed	Lord Carlile of Berriew
uin	HL16303
answer	answer is ministerial correction date of answer 20/06/2019 answer text <p>Transport for London Rail operates shuttle services between Heathrow’s terminals. The scheduling and performance of these services is a matter for Transport for London.</p> answering member printed Baroness Vere of Norbiton question first answered 20/06/2019 13:59:29 answering member 4580 label Biography information for Baroness Vere of Norbiton
tabling member	1138 label Biography information for Lord Carlile of Berriew

1131886

registered interest
date	12/06/2019
answering body	Department for Transport
answering dept id	27
answering dept short name	Transport
answering dept sort name	Transport
hansard heading	Heathrow Airport: Railways
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what plans they have to review the franchise arrangements concerning the shuttle service between Heathrow Central and Terminal 4.
tabling member printed	Lord Carlile of Berriew
uin	HL16304
answer	answer is ministerial correction date of answer 25/06/2019 answer text <p>The rail network at Heathrow is privately owned and is exempt from the franchising requirements of the Railways Act 1993. This means that the Secretary of State cannot designate services on that network for franchising. Train services operating on the Heathrow rail network are not provided under franchise agreements.</p><p> </p> answering member printed Baroness Vere of Norbiton question first answered 25/06/2019 15:09:22 answering member 4580 label Biography information for Baroness Vere of Norbiton
tabling member	1138 label Biography information for Lord Carlile of Berriew

1022862

registered interest
date	10/12/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Mobile Phones: Evidence
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how much funding they have provided in each year since 2012–13 to enable citizens to send the police photo, video and audio evidence of crimes they have captured on their smartphones.
tabling member printed	Lord Carlile of Berriew
uin	HL12133
answer	answer is ministerial correction date of answer 07/01/2019 answer text <p>The Home Office is running an ambitious portfolio of programmes to improve the national technology capabilities available to policing. This includes: the Emergency Services Mobile Communications Programme (ESMCP) providing a single platform for critical voice and data; Home Office Biometrics provides a single platform for fingerprint, facial recognition and DNA; The National Law Enforcement Data Programme provides access across policing to national police information as well as sharing intelligence across forces; The National ANPR Service will unite all local ANPR systems into a single national system; and the Home Office continues to enhance the capabilities of the national Child Abuse Image Database.</p><p>These programmes are replacing aging and obsolete technology, as well as introducing new capabilities, and we are working with policing across this portfolio to support maximisation of the benefits these offer: cash savings, productivity opportunities and better outcomes for the public.</p> answering member printed Baroness Williams of Trafford grouped question UIN HL12134 HL12135 question first answered 07/01/2019 16:53:50 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	1138 label Biography information for Lord Carlile of Berriew

1022863

registered interest
date	10/12/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Mobile Phones: Evidence
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had with the Metropolitan Police Service about the savings it could make by promoting the Self Evident app as a way to (1) obtain photo and video evidence of crimes from victims and witnesses, (2) enable citizens to record an initial witness statement, and (3) provide support for repeat and vulnerable victims.
tabling member printed	Lord Carlile of Berriew
uin	HL12134
answer	answer is ministerial correction date of answer 07/01/2019 answer text <p>The Home Office is running an ambitious portfolio of programmes to improve the national technology capabilities available to policing. This includes: the Emergency Services Mobile Communications Programme (ESMCP) providing a single platform for critical voice and data; Home Office Biometrics provides a single platform for fingerprint, facial recognition and DNA; The National Law Enforcement Data Programme provides access across policing to national police information as well as sharing intelligence across forces; The National ANPR Service will unite all local ANPR systems into a single national system; and the Home Office continues to enhance the capabilities of the national Child Abuse Image Database.</p><p>These programmes are replacing aging and obsolete technology, as well as introducing new capabilities, and we are working with policing across this portfolio to support maximisation of the benefits these offer: cash savings, productivity opportunities and better outcomes for the public.</p> answering member printed Baroness Williams of Trafford grouped question UIN HL12133 HL12135 question first answered 07/01/2019 16:53:50 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	1138 label Biography information for Lord Carlile of Berriew

1022865

registered interest
date	10/12/2018
answering body	Home Office
answering dept id	1
answering dept short name	Home Office
answering dept sort name	Home Office
hansard heading	Mobile Phones: Evidence
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what discussions they have had with the Metropolitan Police Service about how much it estimates the annual cost of using the Self Evident app would be.
tabling member printed	Lord Carlile of Berriew
uin	HL12135
answer	answer is ministerial correction date of answer 07/01/2019 answer text <p>The Home Office is running an ambitious portfolio of programmes to improve the national technology capabilities available to policing. This includes: the Emergency Services Mobile Communications Programme (ESMCP) providing a single platform for critical voice and data; Home Office Biometrics provides a single platform for fingerprint, facial recognition and DNA; The National Law Enforcement Data Programme provides access across policing to national police information as well as sharing intelligence across forces; The National ANPR Service will unite all local ANPR systems into a single national system; and the Home Office continues to enhance the capabilities of the national Child Abuse Image Database.</p><p>These programmes are replacing aging and obsolete technology, as well as introducing new capabilities, and we are working with policing across this portfolio to support maximisation of the benefits these offer: cash savings, productivity opportunities and better outcomes for the public.</p> answering member printed Baroness Williams of Trafford grouped question UIN HL12133 HL12134 question first answered 07/01/2019 16:53:50 answering member 4311 label Biography information for Baroness Williams of Trafford
tabling member	1138 label Biography information for Lord Carlile of Berriew

984260

registered interest
date	09/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Buprenorphine
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what action they are taking (1) to remedy any buprenorphine shortage, and (2) to ensure that in the long term there is consistent and adequate supply of this medication, that it is available across the country and is not subject to unpredictable price fluctuations.
tabling member printed	Lord Carlile of Berriew
uin	HL10468
answer	answer is ministerial correction date of answer 17/10/2018 answer text <p>We are aware that there was a short-term supply issue which may have affected the availability in May 2018. This was because one of the main suppliers experienced delays in delivery, resulting in a short term out of stock period. Although supplies continued to remain available from other suppliers, we are aware that some may have struggled to support the increase in demand at short notice. The delivery issues were resolved quickly and the overall supply of buprenorphine tablets improved shortly afterwards.</p><p>Since this period, the Department has remained in regular contact with all United Kingdom licensed suppliers of buprenorphine and has been working closely with them to monitor their supply position. Based on these conversations, we have been assured that the available supplies are sufficient to meet the usual UK requirements for this drug. The Department continues to monitor this very closely to ensure that there is consistent and adequate supply of this medication across the country.</p><p>The Department is aware that since this short-term supply issue, the market price has increased. This increased purchase price is reflected in the reimbursement price paid to pharmacies, to ensure that supplies remain available to patients. The market for buprenorphine has generally been competitive and we expect the supply situation to improve over the coming weeks which is likely to result in an increasingly competitive market.</p><p> </p> answering member printed Lord O'Shaughnessy question first answered 17/10/2018 15:25:57 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1138 label Biography information for Lord Carlile of Berriew

979709

registered interest
date	01/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government how many technology appraisals NICE has undertaken for medicines which have successfully passed through the Early Access to Medicines Scheme; and how long it has taken for a NICE recommendation to be reached on each of those appraisals.
tabling member printed	Lord Carlile of Berriew
uin	HL10366
answer	answer is ministerial correction date of answer 15/10/2018 answer text <p>To date, the National Institute for Health and Care Excellence (NICE) has published final technology appraisal guidance on 18 drugs with a positive Scientific Opinion through the Early Access to Medicines Scheme. Information on the length of time between receipt of a positive Scientific Opinion and final NICE technology appraisal guidance for each drug is attached due to the size of the data.</p> answering member printed Lord O'Shaughnessy question first answered 15/10/2018 10:56:04 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name HL10366 table formatted.docx title Time between Scientific Opinion and NICE guidance
tabling member	1138 label Biography information for Lord Carlile of Berriew

980121

registered interest
date	01/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glioblastoma: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government whether new biomarker-linked treatments for glioblastoma multiforme would be considered candidate technologies for the Accelerated Access Pathway under the Accelerated Access Review.
tabling member printed	Lord Carlile of Berriew
uin	HL10390
answer	answer is ministerial correction date of answer 15/10/2018 answer text <p>As set out in the response to the Accelerated Access Review, the Accelerated Access Pathway (AAP) will focus on affordable products which can dramatically improve efficiency, fill an unmet need or make a step change in patient outcomes.</p><p>There are no restrictions on what type of products the AAP should focus on. The AAP will be launched shortly after the next meeting of the Accelerated Access Collaborative.</p> answering member printed Lord O'Shaughnessy question first answered 15/10/2018 11:01:04 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1138 label Biography information for Lord Carlile of Berriew

980122

registered interest
date	01/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Glioblastoma: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what steps they are taking to support future patient access to new and clinically-effective medicines for glioblastoma multiforme.
tabling member printed	Lord Carlile of Berriew
uin	HL10391
answer	answer is ministerial correction date of answer 15/10/2018 answer text <p>A number of drugs currently being developed for potential use in the treatment of glioblastoma have been referred to the National Institute for Health and Care Excellence (NICE) for the development of technology appraisal guidance. New arrangements for the assessment and adoption of cancer drugs were introduced in 2016 that are designed to ensure that patients benefit from rapid access to the most promising new cancer drugs. Under these arrangements, wherever possible, NICE aims to publish draft guidance on cancer drugs before the product receives a marketing authorisation for use in the United Kingdom, and drugs recommended in draft NICE guidance will be eligible for Cancer Drugs Fund funding from the time that the drug receives a marketing authorisation.</p><p>In May, the Government announced £40 million for brain cancer research in honour of Dame Tessa Jowell. Funding will be invested through the National Institute for Health Research to support a wide range of research from early translation (experimental medicine) through clinical and on to applied research. This will support the translation of laboratory discoveries into treatments and better care for patients.</p><p> </p><p> </p> answering member printed Lord O'Shaughnessy question first answered 15/10/2018 15:36:13 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1138 label Biography information for Lord Carlile of Berriew

980123

registered interest
date	01/10/2018
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty's Government what assessment they have made of the implementation of the recommendations of the Independent Review of the Early Access to Medicines Scheme.
tabling member printed	Lord Carlile of Berriew
uin	HL10392
answer	answer is ministerial correction date of answer 15/10/2018 answer text <p>Since the publication of the independent review of the Early Access to Medicines Scheme (EAMS) the Government has made a number of improvements.</p><p>Partners have worked together to provide updated guidance on the benefits and entry requirements for EAMS and are developing further guidance on collecting real world data in the scheme to support National Institute for Health and Care Excellence appraisal.</p><p>Furthermore, the EAMS task group exists to provide a forum for industry to engage with Government, the devolved administrations and arm’s length bodies regarding EAMS, as per the recommendations of the 2016 review.</p> answering member printed Lord O'Shaughnessy question first answered 15/10/2018 13:52:46 answering member 4545 label Biography information for Lord O'Shaughnessy
tabling member	1138 label Biography information for Lord Carlile of Berriew